RealFeedApp Immunity protects against HIV infection
Clinical trials of antibody-mediated prevention (AMP) using intravenous bnAb VRC01 demonstrated efficacy, yet resistant HIV-1 strains successfully bypassed this protection.
- Field
- gene therapy
- What they did
- Researchers conducted clinical trials of the VRC01 antibody, which is administered intravenously to prevent HIV-1 infection in HIV-negative individuals.
- Why it matters
- This method could protect people at high risk of infection, including those who cannot or prefer not to use conventional PrEP.
#hiv#bnab#vrc01#antibody-mediated prevention#clinical trial
